Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 6, 2002, Pages 925-934

  Miller, Keith ^a   O'Neill, Alexander John ^a   Chopra, Ian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CYCLOSERINE; DNA TOPOISOMERASE (ATP HYDROLYSING); POLYMYXIN B; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CALCULATION; CODON; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EXPOSURE; ESCHERICHIA COLI; GENE MUTATION; HOST; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MUTATION; STATISTICS;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MUTATION; RIFAMPIN;

EID: 0035992117     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf044     Document Type: Article

References (49)

1. Changing patterns of infectious disease
2. Discovery and development of new antibiotics: The problem of antibiotic resistance
3. Resistance to antibiotics mediated by target alterations
4. Mutation frequencies and antibiotic resistance
5. High mutation frequencies among Escherichia coli and Salmonella pathogens
6. Hypermutation in pathogenic bacteria: Frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype
7. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
8. The rise and fall of mutator bacteria
9. A conspicuous adaptability to antibiotics in the Escherichia coli mutator strain, dnaQ49
10. A guide to sensitivity testing. Report of the working party on antibiotic sensitivity testing of the British Society for Antimicrobial Chemotherapy
11. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus
12. Gene mutation
13. Growth measurement
14. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae
15. Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus
16. Mutational analysis of structure-function relationship of RNA polymerase in Escherichia coli
17. Topoisomerase IV is a target of quinolones in Escherichia coli
18. Regulation of chromosomally-mediated multiple antibiotic resistance: The mar regulon
19. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli
20. Intracellular steps of bacterial cell wall peptidoglycan biosynthesis-enzymology, antibiotics, and antibiotic-resistance
21. Beta-lactams: Mode of action and mechanisms of bacterial resistance
22. Role of permeability barriers in resistance to β-lactam antibiotics
23. Transport of antibiotics into bacteria
24. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production
25. Multiple antibiotic resistance and efflux
26. In vitro antibacterial properties of pexiganan, an analog of magainin
27. Cationic peptides
28. Decreased membrane permeability in a polymyxin B-resistant Escherichia coli mutant exhibiting multiple resistance to β-lactams as well as aminoglycosides
29. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli
30. Interaction between DNA gyrase and quinolones: Effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87)
31. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis
32. Resistance to D-cycloserine in the tubercle bacilli: Mutation rate and transport of alanine in parental cells and drug-resistant mutants
33. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals
34. Mechanisms of bacterial resistance to quinolones
35. Research and development of antibacterial agents
36. Genomics and antimicrobial drug discovery
37. Antibacterial drug discovery: Progress with current targets
38. Harnessing the power of the genome in the search for new antibiotics
39. Use of mutator strains for characterization of novel antimicrobial agents
40. Bacterial antibiotic resistance
41. Use of mutator strains for characterization of novel antimicrobial agents-reply
42. Escherichia coli mutator genes
43. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance
44. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli
45. Isolation, characterization, and genetic analysis of mutator genes in Escerichia coli B and K-12
46. A Short Course in Bacterial Genetics